Immunomedics Inc (NASDAQ:IMMU)

18.36
Delayed Data
As of Feb 14
 -0.40 / -2.13%
Today’s Change
11.59
Today|||52-Week Range
22.22
-13.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
AssetsCash580.6M492.9M439.2M429.2M
 
 
 
 
 
Short Term Investment Cash-----54.9M-10.0M
 
 
 
Cash & Short Term Investments585.5M497.8M444.0M434.0M
 
 
 
 
 
 
ReceivablesReceivables--0.000.000.00--
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses--5.4M4.9M8.3M
 
 
 
 
Other Current Assets8.5M1.3M0.000.00
 
 
 
Current Assets594.0M504.5M448.9M442.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross50.0M27.8M40.6M41.4M
 
 
 
 
 
Depreciation-31.4M-4.3M-5.1M-6.3M
 
 
 
 
 
Other Assets61.0K68.0K269.0K249.0K
 
 
 
 
 
Total Assets612.7M528.0M484.6M477.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable33.7M31.7M53.9M39.0M
 
 
 
 
 
Short Term Debt----2.7M5.6M
 
 
 
Other Current Liabilities10.5M0.00298.0K0.00
 
 
 
Other Liabilities44.2M31.7M56.9M44.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt19.8M7.1M235.7M253.6M
 
 
 
 
 
Other Liabilities209.4M223.4M10.2M0.00
 
 
 
 
Total Liabilities273.3M262.2M302.8M363.1M
 
 
 
 
 
 
EquityMinority Interest-40.0K-139.1K-67.0K0.00
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity343.8M266.8M182.8M115.5M
 
 
 
 
 
Total Shareholder Equity343.8M266.8M182.8M115.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding187.1M190.4M191.4M191.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.